Confluent Surgical Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	33
ISBN Number	not applicable
Product Code	GMD04739

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Confluent Surgical Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Key Employees
5 Locations And Subsidiaries
5.1 Head Office
6 Recent Developments
6.1 Product News
- 6.1.1 Feb 02, 2006: DuraSeal Sealant Receives CE Mark For Vascular Applications
- 6.1.2 Oct 07, 2005: DuraSeal Sealant CE Mark For Thoracic Applications
- 6.1.3 Sep 23, 2005: Confluent Surgical Announces DuraSeal Xact System Receives CE Mark For Spine Applications
- 6.1.4 Apr 07, 2005: FDA Approves First Cranial Dural Sealant
- 6.1.5 Jun 17, 2002: Confluent Surgical Announces First Procedure In U.S. Trial For SprayGel Adhesion Barrier
6.2 Product Approvals
- 6.2.1 Oct 07, 2005: DuraSeal Sealant CE Mark For Thoracic Applications
- 6.2.2 Sep 23, 2005: Confluent Surgical Announces DuraSeal Xact System Receives CE Mark For Spine Applications
- 6.2.3 Apr 07, 2005: FDA Approves First Cranial Dural Sealant
7 Confluent Surgical Inc. Pipeline Products
7.1 Confluent Surgical Inc. Product Pipeline Analysis
- 7.1.1 Confluent Surgical Inc. Pipeline Products By Equipment Type
- 7.1.2 Confluent Surgical Inc. Pipeline Products By Development Stage
- 7.1.3 Confluent Surgical Inc. Pipeline Products By Therapy Area
- 7.1.4 Confluent Surgical Inc. Pipeline Products By Clinical Trials
- 7.1.5 Confluent Surgical Inc. Pipeline Products By News Summary
7.2 DuraSeal Xact Adhesion Barrier & Sealant System
- 7.2.1 Product Description
- 7.2.2 Product Status
- 7.2.3 Clinical Trials
- 7.2.4 Product Milestone
7.3 Advanced SprayGel Adhesion Barrier
- 7.3.1 Product Description
- 7.3.2 Product Status
- 7.3.3 Clinical Trials
- 7.3.4 Product Milestone
7.4 DuraSeal Sealant System
- 7.4.1 Product Description
- 7.4.2 Product Status
- 7.4.3 Clinical Trials
- 7.4.4 Product Milestone
8 Appendix
8.1 Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Expert Panel Validation
8.2 Contact Us
8.3 About Global Markets Direct
8.4 Disclaimer
1 List of Tables
Table 1: Confluent Surgical Inc.,Key Facts
Table 2: Confluent Surgical Inc., Key Employees,
Table 3: Confluent Surgical Inc. Pipeline Products by Equipment Type
Table 4: Confluent Surgical Inc. Pipeline Products By Development Stage
Table 5: Confluent Surgical Inc. Pipeline Products By Therapy Area
Table 6: Confluent Surgical Inc. Pipeline Products By Clinical Trials
Table 7: Confluent Surgical Inc. Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: Confluent Surgical Inc. Pipeline Products By Development Stage
Figure 2: Confluent Surgical Inc. Pipeline Products By News Summary
Figure 3: Global Markets Direct Methodology